EARLY EVALUATION OF HISTOLOGICAL MARKERS OF FIBROSIS AND CELLULAR PROLIFERATION IN LIVER TRANSPLANT PATIENTS WITH HCV RECURRENCE

被引：0
|
作者：
Mensa, L. [1 ]
Marino, Z. [1 ]
Crespo, G. [1 ]
Lens, S. [1 ]
Miquel, R. [2 ]
Carrion, J. [1 ]
Perez-del-Pulgar, S. [1 ]
Forns, X. [1 ]
Navasa, M. [1 ]
机构：
[1] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Liver Unit, Barcelona, Spain
[2] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Dept Pathol, Barcelona, Spain
来源：
JOURNAL OF HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
10.1016/S0168-8278(13)60171-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
169
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] Early HCV RNA levels and "super-recurrence" predict advanced allograft fibrosis at 1-year in patients undergoing liver transplant for HCV
    O'Leary, Jacqueline G.
    Elias, Nahel
    Hertl, Martin
    Pratt, Daniel S.
    Cosimi, Anthony B.
    Chung, Raymond T.
    HEPATOLOGY, 2006, 44 (04) : 477A - 477A
  • [2] Liver Fibrosis in Patients with HCV Recurrence After Liver Transplantation: Early Protective Role of N-Acetylcisteine
    D'Amico, Francesco
    Burra, Patrizia
    Bertacco, Alessandra
    Zanetto, Alberto
    Cillo, Umberto
    TRANSPLANTATION, 2015, 99 : 145 - 146
  • [3] Recurrence of HCV infection in liver transplant patients: Evaluation of IgM Anti-HCV and IgM Anti-CMV
    Ceccherini-Nelli, L
    Giannotti, A
    Malizia, T
    Ciccorossi, P
    Olivieri, F
    Vanni, M
    Lico, S
    Campani, D
    Filipponi, F
    Brunetto, M
    Mosca, F
    Campa, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1030 - 1031
  • [4] Does MMF really slow down fibrosis of HCV recurrence in liver transplant recipients?
    Germani, Giacomo
    Tsochatzis, Emmanuel
    Burroughs, Andrew Kenneth
    TRANSPLANT INTERNATIONAL, 2011, 24 (09) : E77 - E78
  • [5] Early identification of recipients with more severe histological recurrence of HCV following liver transplantation
    Charlton, M
    Raghavakaimal, S
    Gonzalez-Koch, A
    Poterucha, J
    Zein, N
    Harmsen, W
    Therneau, T
    Rosen, C
    Wiesner, R
    TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [6] Transcriptome Distinguish HCV Recurrence from Acute Cellular Rejection in HCV Recipients Post-Liver Transplant
    Gehrau, Ricardo
    Maluf, Daniel
    Archer, Kellie
    Mas, Valeria
    LIVER TRANSPLANTATION, 2011, 17 (06) : S204 - S204
  • [7] Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence
    Teegen, Eva M.
    Duerr, Michael
    Maurer, Max M.
    Eurich, Franziska
    Vollbort, Antonia
    Globke, Brigitta
    Bahra, Marcus
    Blaeker, Hendrik
    Pratschke, Johann
    Eurich, Dennis
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (01)
  • [8] IMMUNO-MODULATING EFFECTS OF SILIBININ IN LIVER TRANSPLANT PATIENTS WITH HCV RECURRENCE
    Castellaneta, A.
    Massaro, A.
    Rendina, M.
    Castellaneta, N. M.
    D'Errico, F.
    Tucci, A.
    Chiala', C.
    Brambilla, N.
    Giacovelli, G.
    Rovati, L.
    D'Amato, M.
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : E67 - E67
  • [9] Immuno-modulating effects of Silibinin in liver transplant patients with HCV recurrence
    Castellaneta, Antonino
    Massaro, Antonio
    Rendina, Maria
    Castellaneta, Nicola Maurizio
    Zappimbulso, Marianna
    Derrico, Francesca
    Brambilla, Nadia
    Giacovelli, Giampaolo
    Rovati, Lucio
    D'Amato, Massimo
    Di Leo, Alfredo
    HEPATOLOGY, 2013, 58 : 370A - 370A
  • [10] Management of HCV recurrence with PEG IFN and ribavirin in post liver transplant patients
    Basnotra, A.
    Saigal, S.
    Nundy, S.
    Soin, A. S.
    Kakador, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A368 - A368
12345